Unidad de Investigación, Hospital Universitario Nuestra Señora de Candelaria, Carretera del Rosario 145, 38010 Santa Cruz de Tenerife, Spain.
Chem Res Toxicol. 2011 Dec 19;24(12):2106-8. doi: 10.1021/tx2004618. Epub 2011 Nov 22.
β-Lapachone (β-lap) is a promising antitumoral agent. DNA base oxidation and alkylation are among the expected damages by β-lap. Herein, we have explored the role that the homologous recombination pathway (HR), a critical DNA repair process in Saccharomyces cerevisiae, has in the cytotoxic profile of β-lap. We have further compared β-lap to the closely related compound menadione and the well-known alkylating agent methyl methanesulfonate (MMS). Surprisingly, we found that β-lap does not trigger HR, as seen for (i) the mutant sensitivity profiles, (ii) concentration-dependent arrest profiles, (iii) absence of nuclear DNA repair factories, and (iv) frequency of recombination between direct repeats.
β-拉帕醌(β-lap)是一种很有前途的抗肿瘤药物。β-拉帕醌可能导致 DNA 碱基氧化和烷基化等损伤。在这里,我们研究了同源重组途径(HR)在酿酒酵母的 DNA 修复过程中的作用,探讨了其在β-拉帕醌细胞毒性特征中的作用。我们还将β-拉帕醌与密切相关的化合物甲萘醌和著名的烷化剂甲磺酸甲酯(MMS)进行了比较。令人惊讶的是,我们发现β-拉帕醌不会触发 HR,这表现在(i)突变体敏感性谱,(ii)浓度依赖性阻滞谱,(iii)不存在核 DNA 修复工厂,以及(iv)直接重复序列之间的重组频率。